{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:28:13Z","timestamp":1769909293476,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T00:00:00Z","timestamp":1396396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/ja.2014.25","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T06:27:41Z","timestamp":1396420061000},"page":"425-432","source":"Crossref","is-referenced-by-count":15,"title":["The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans"],"prefix":"10.1038","volume":"67","author":[{"given":"Monika","family":"Staniszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Bondaryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Urba\u0144czyk-Lipkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BFja201425_CR1","doi-asserted-by":"publisher","first-page":"E389","DOI":"10.1111\/j.1469-0691.2012.03973.x","volume":"18","author":"P Zarb","year":"2012","unstructured":"Zarb, P. et al. Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clin. Microbiol. Infect. 18, E389\u2013E395 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFja201425_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani, Z. A. & Perfect, J. R. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin. Infect. Dis. 46, 120\u2013128 (2008).","journal-title":"Clin. Infect. Dis."},{"key":"BFja201425_CR3","first-page":"63","volume":"44","author":"Anon","year":"2002","unstructured":"Anon. Voriconazole. Med. Lett. Drugs Ther. 44, 63\u201365 (2002).","journal-title":"Med. Lett. Drugs Ther."},{"key":"BFja201425_CR4","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1016\/j.ejmech.2010.06.012","volume":"45","author":"B Fang","year":"2010","unstructured":"Fang, B., Zhou, C. H. & Rao, X. C. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents. Eur. J. Med. Chem. 45, 4388\u20134398 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"BFja201425_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","volume":"4","author":"FL Mayer","year":"2013","unstructured":"Mayer, F. L., Wilson, D. & Hube, B. Candida albicans pathogenicity mechanisms. Virulence 4, 119\u2013128 (2013).","journal-title":"Virulence"},{"key":"BFja201425_CR6","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2174\/092986711795843182","volume":"18","author":"LA Braga-Silva","year":"2011","unstructured":"Braga-Silva, L. A. & Santos, A. L. S. Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis. Curr. Med. Chem. 18, 2401\u20132419 (2011).","journal-title":"Curr. Med. Chem."},{"key":"BFja201425_CR7","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1016\/j.bmc.2012.09.031","volume":"20","author":"C Calugi","year":"2012","unstructured":"Calugi, C. et al. Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) form Candida albicans reveal a constrained inhibitory chemotype. Bioorg. Med. Chem. 20, 7206\u20137213 (2012).","journal-title":"Bioorg. Med. Chem."},{"key":"BFja201425_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1462-5822.2009.01394.x","volume":"12","author":"F Dalle","year":"2010","unstructured":"Dalle, F. et al. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol. 12, 248\u2013271 (2010).","journal-title":"Cell Microbiol."},{"key":"BFja201425_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijmm.2011.04.009","volume":"301","author":"R Martin","year":"2011","unstructured":"Martin, R., W\u00e4chtler, B., Schaller, M., Wilson, D. & Hube, B. Host-pathogen interaction and virulence-associated genes during Candida albicans oral infections. Int. J. Med. Microbiol. 301, 417\u2013422 (2011).","journal-title":"Int. J. Med. Microbiol."},{"key":"BFja201425_CR10","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1167\/iovs.07-0114","volume":"48","author":"BE Jackson","year":"2007","unstructured":"Jackson, B. E., Wilhelmus, K. R. & Hube, B. The role of secreted aspartyl proteinases in Candida albicans keratitis. Invest. Ophthal. Vis. Sci. 48, 3559\u20133565 (2007).","journal-title":"Invest. Ophthal. Vis. Sci."},{"key":"BFja201425_CR11","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1128\/IAI.00248-10","volume":"78","author":"A Correia","year":"2010","unstructured":"Correia, A. et al. Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect. Immun. 78, 4839\u20134849 (2010).","journal-title":"Infect. Immun."},{"key":"BFja201425_CR12","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1128\/jb.177.18.5215-5221.1995","volume":"177","author":"TC White","year":"1995","unstructured":"White, T. C. & Agabian, N. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J. Bacteriol. 177, 5215\u20135221 (1995).","journal-title":"J. Bacteriol."},{"key":"BFja201425_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1128\/IAI.73.3.1828-1835.2005","volume":"73","author":"BN Taylor","year":"2005","unstructured":"Taylor, B. N. et al. Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infect. Immun. 73, 1828\u20131835 (2005).","journal-title":"Infect. Immun."},{"key":"BFja201425_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bcp.2012.12.008","volume":"85","author":"CD Cadicamo","year":"2013","unstructured":"Cadicamo, C. D. et al. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. Biochem. Pharmacol. 85, 881\u2013887 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"BFja201425_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.micinf.2011.06.009","volume":"13","author":"JR Naglik","year":"2011","unstructured":"Naglik, J. R., Moyes, D. L., W\u00e4chtler, B. & Hube, B. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect. 13, 963\u2013976 (2011).","journal-title":"Microbes Infect."},{"key":"BFja201425_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2958.1994.tb01269.x","volume":"14","author":"B Hube","year":"1994","unstructured":"Hube, B., Monod, M., Schofield, D. A., Brown, A. J. P. & Gow, N. A. R. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14, 87\u201399 (1994).","journal-title":"Mol. Microbiol."},{"key":"BFja201425_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.33073\/pjm-2012-034","volume":"61","author":"M Staniszewska","year":"2012","unstructured":"Staniszewska, M. et al. In vitro study of secreted aspartyl proteinases Sap1 to Sap3 and Sap4 to Sap6 expression in Candida albicans pleomorphic forms. Pol. J. Microbiol. 61, 247\u2013256 (2012).","journal-title":"Pol. J. Microbiol."},{"key":"BFja201425_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","volume":"67","author":"JR Naglik","year":"2003","unstructured":"Naglik, J. R., Challacombe, S. J. & Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400\u2013428 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"BFja201425_CR19","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1099\/mic.0.2008\/022293-0","volume":"154","author":"JR Naglik","year":"2008","unstructured":"Naglik, J. R. et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 154, 3266\u20133280 (2008).","journal-title":"Microbiology"},{"key":"BFja201425_CR20","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1099\/mic.0.2008\/022525-0","volume":"154","author":"U Lermann","year":"2008","unstructured":"Lermann, U. & Morschh\u00e4user, J. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 154, 3281\u20133295 (2008).","journal-title":"Microbiology"},{"key":"BFja201425_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1590\/S0100-879X2009000800013","volume":"42","author":"LA Braga-Silva","year":"2009","unstructured":"Braga-Silva, L. A. et al. Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases. Braz. J. Med. Biol. Res. 42, 765\u2013770 (2009).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFja201425_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijmm.2012.12.006","volume":"303","author":"A Bertini","year":"2013","unstructured":"Bertini, A. et al. Comparison of Candida parapsislosis, Candida orthopsilosis, and Candida methapsislosis adhesive properties and pathogenicity. Int. J. Med. Microbiol. 303, 98\u2013103 (2013).","journal-title":"Int. J. Med. Microbiol."},{"key":"BFja201425_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","volume":"90","author":"HJ Lo","year":"1997","unstructured":"Lo, H. J. et al. Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939\u2013949 (1997).","journal-title":"Cell"},{"key":"BFja201425_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.33073\/pjm-2012-016","volume":"61","author":"M Staniszewska","year":"2012","unstructured":"Staniszewska, M., Bondaryk, M., Siennicka, K. & Kurz\u0105tkowski, W. Ultrastructure of Candida albicans pleomorphic forms: phase-contrast microscopy, scanning and transmission electron microscopy. Pol. J. Microbiol. 61, 129\u2013135 (2012).","journal-title":"Pol. J. Microbiol."},{"key":"BFja201425_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11046-012-9539-6","volume":"174","author":"M Moazeni","year":"2012","unstructured":"Moazeni, M. et al. RNA-mediated gene silencing in Candida albicans: inhibition of hyphae formation by use of RNAi technology. Mycopathologia 174, 177\u2013185 (2012).","journal-title":"Mycopathologia"},{"key":"BFja201425_CR26","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1128\/JCM.37.11.3481-3486.1999","volume":"37","author":"F De Bernardis","year":"1999","unstructured":"De Bernardis, F., Mondello, F., San Milan, R., Ponton, J. & Cassone, A. Biotyping virulence properties of skin isolates of Candida parapsilosis. J. Clin. Microbiol. 37, 3481\u20133486 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"BFja201425_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1086\/314871","volume":"180","author":"A Cassone","year":"1999","unstructured":"Cassone, A. et al. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis. 180, 448\u2013453 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFja201425_CR28","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1128\/AAC.43.8.2038","volume":"43","author":"HC Korting","year":"1999","unstructured":"Korting, H. C. et al. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob. Agents Chemother. 43, 2038\u20132042 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201425_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1523-1747.1999.00747.x","volume":"113","author":"M Borg-von Zepelin","year":"1999","unstructured":"Borg-von Zepelin, M. et al. HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J. Invest. Dermatol. 113, 747\u2013751 (1999).","journal-title":"J. Invest. Dermatol."},{"key":"BFja201425_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1567-1364.2009.00595.x","volume":"10","author":"LA Braga-Silva","year":"2010","unstructured":"Braga-Silva, L. A., Mogami, S. S., Valle, R. S., Silva-Neto, I. D. & Santos, A. L. S. Multiple effects of amprenavir against Candida albicans. FEMS Yeast Res. 10, 221\u2013224 (2010).","journal-title":"FEMS Yeast Res."},{"key":"BFja201425_CR31","first-page":"1227","volume":"341","author":"Z Fujimoto","year":"2004","unstructured":"Fujimoto, Z., Fujii, Y., Kaneko, S., Kobayashi, H. & Mizuno, H. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin. J. Biol. Chem. 341, 1227\u20131235 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFja201425_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cbic.200500180","volume":"7","author":"C Binkert","year":"2006","unstructured":"Binkert, C. et al. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases. Chembiochem. 7, 181\u2013186 (2006).","journal-title":"Chembiochem."},{"key":"BFja201425_CR33","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.3390\/molecules18067120","volume":"18","author":"P Polcyn","year":"2013","unstructured":"Polcyn, P. et al. Novel antimicrobial peptide dendrimers with amphiphilic surface and their interactions with phospholipids\u2014insights from mass spectrometry. Molecules 18, 7120\u20137144 (2013).","journal-title":"Molecules"},{"key":"BFja201425_CR34","doi-asserted-by":"publisher","first-page":"19298","DOI":"10.1074\/jbc.271.32.19298","volume":"271","author":"TJ Falla","year":"1996","unstructured":"Falla, T. J., Karunaratne, D. N. & Hancock, R. E. W. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271, 19298\u201319303 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFja201425_CR35","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1128\/AAC.00319-11","volume":"55","author":"T Rossignol","year":"2011","unstructured":"Rossignol, T., Kelly, B., Dobson, C. & d\u2019Enfert, C. Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans. Antimicrob. Agents Chemother. 55, 4670\u20134681 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201425_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0006-291X(02)00222-X","volume":"293","author":"DG Lee","year":"2002","unstructured":"Lee, D. G. et al. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem. Biophys. Res. Commun. 293, 231\u2013238 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFja201425_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00328721","volume":"198","author":"AM Gillum","year":"1984","unstructured":"Gillum, A. M., Tsay, E. Y. & Kirsch, D. R. Isolation of the Candida albicans gene for orotidine-5\u2032-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol.Gen. Genet. 198, 179\u2013182 (1984).","journal-title":"Mol.Gen. Genet."},{"key":"BFja201425_CR38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/genetics\/134.3.717","volume":"134","author":"WA Fonzi","year":"1993","unstructured":"Fonzi, W. A. & Irwin, M. Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717\u2013728 (1993).","journal-title":"Genetics"},{"key":"BFja201425_CR39","doi-asserted-by":"publisher","first-page":"e46020","DOI":"10.1371\/journal.pone.0046020","volume":"7","author":"S Puri","year":"2012","unstructured":"Puri, S. et al. Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis. PLoS ONE 7, e46020 (2012).","journal-title":"PLoS ONE"},{"key":"BFja201425_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1128\/EC.00210-10","volume":"10","author":"L Schild","year":"2011","unstructured":"Schild, L. et al. Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10. Eukaryot. Cell 10, 98\u2013109 (2011).","journal-title":"Eukaryot. Cell"},{"key":"BFja201425_CR41","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1126\/science.7992058","volume":"266","author":"H Liu","year":"1994","unstructured":"Liu, H., K\u00f6hler, J. & Fink, G. R. Suppression of hyphal formation in Candida albicans by mutation of STE12 homolog. Science 266, 1723\u20131726 (1994).","journal-title":"Science"},{"key":"BFja201425_CR42","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing Standard M27-A2 2nd edn 1\u201329 Wayne (Clinical and Laboratory Standards Institute: USA, (2002)."},{"key":"BFja201425_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bmc.2009.11.009","volume":"18","author":"FM Garibotto","year":"2010","unstructured":"Garibotto, F. M. et al. New small-size peptides possessing antifungal activity. Bioorg. Med. Chem. 18, 158\u2013167 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"BFja201425_CR44","first-page":"127","volume-title":"Methods in Yeast Genetics","author":"DC Amberg","year":"2005","unstructured":"Amberg, D. C., Burke, D. J. & Strathern, J. N. In Methods in Yeast Genetics eds Amberg D. C., Burke D. J., Strathern J. N., 127\u2013131 Cold Spring Harbor Laboratory Press, (2005)."},{"key":"BFja201425_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013428 (2001).","journal-title":"Methods"},{"key":"BFja201425_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1128\/EC.05206-11","volume":"11","author":"M Zavrel","year":"2012","unstructured":"Zavrel, M., Majer, O., Kuchler, K. & Rupp, S. Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans. Eukaryot. Cell 11, 129\u2013140 (2012).","journal-title":"Eukaryot. Cell"},{"key":"BFja201425_CR47","doi-asserted-by":"publisher","first-page":"528521","DOI":"10.1155\/2012\/528521","volume":"2012","author":"G Ramage","year":"2012","unstructured":"Ramage, G., Rajendran, R., Sherry, L. & Williams, C. Fungal biofilm resistance. Int. J. Microbiol. 2012, 528521 (2012).","journal-title":"Int. J. Microbiol."},{"key":"BFja201425_CR48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.fgb.2010.08.005","volume":"47","author":"V \u0160tov\u00ed\u010dek","year":"2010","unstructured":"\u0160tov\u00ed\u010dek, V., V\u00e1chov\u00e1, L., Kuthan, M. & Palkov\u00e1, Z. General factors important for the formation of structured biofilm-like yeast colonies. Fungal Genet. Biol. 47, 1012\u20131022 (2010).","journal-title":"Fungal Genet. Biol."},{"key":"BFja201425_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1874285801105010119","volume":"5","author":"N D\u00e9canis","year":"2011","unstructured":"D\u00e9canis, N., Tazi, N., Correia, A., Vilanova, M. & Rouabhia, M. Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes. Open Microbiol. J. 5, 119\u2013126 (2011).","journal-title":"Open Microbiol. J."},{"key":"BFja201425_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10529-010-0402-x","volume":"33","author":"C Park","year":"2011","unstructured":"Park, C., Cho, J., Lee, J. & Lee, D. G. Membranolytic antifungal activity of arenicin-1 requires the N-terminal tryptophan and the beta-turn arginine. Biotechnol. Lett. 33, 185\u2013189 (2011).","journal-title":"Biotechnol. Lett."},{"key":"BFja201425_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/bit.25003","volume":"111","author":"R Saravanan","year":"2014","unstructured":"Saravanan, R. et al. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility. Biotechnol. Bioeng. 111, 37\u201349 (2014).","journal-title":"Biotechnol. Bioeng."},{"key":"BFja201425_CR52","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1039\/b921248e","volume":"8","author":"AP Podorieszach","year":"2010","unstructured":"Podorieszach, A. P. & Huttunen-Hennelly, H. E. K. The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin with promising pharmaceutical potential. Org. Biomol. Chem. 8, 1679\u20131687 (2010).","journal-title":"Org. Biomol. Chem."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201425","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:21:12Z","timestamp":1684430472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,2]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFja201425"],"URL":"https:\/\/doi.org\/10.1038\/ja.2014.25","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,2]]}}}